Annual Current Liabilities
$95.03 M
-$168.31 M-63.91%
31 December 2023
Summary:
Pacific Biosciences of California annual total current liabilities is currently $95.03 million, with the most recent change of -$168.31 million (-63.91%) on 31 December 2023. During the last 3 years, it has risen by +$56.53 million (+146.82%). PACB annual current liabilities is now -63.91% below its all-time high of $263.33 million, reached on 31 December 2022.PACB Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Liabilities
$60.00 M
-$18.39 M-23.46%
30 September 2024
Summary:
Pacific Biosciences of California quarterly total current liabilities is currently $60.00 million, with the most recent change of -$18.39 million (-23.46%) on 30 September 2024. Over the past year, it has dropped by -$123.96 million (-67.39%). PACB quarterly current liabilities is now -77.89% below its all-time high of $271.41 million, reached on 30 June 2023.PACB Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PACB Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -63.9% | -67.4% |
| 3 y3 years | +146.8% | +7.9% |
| 5 y5 years | +253.5% | +18.4% |
PACB Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -63.9% | +146.8% | -77.9% | +7.9% |
| 5 y | 5 years | -63.9% | +253.5% | -77.9% | +77.8% |
| alltime | all time | -63.9% | +1921.0% | -77.9% | +612.6% |
Pacific Biosciences Of California Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $60.00 M(-23.5%) |
| June 2024 | - | $78.39 M(+7.5%) |
| Mar 2024 | - | $72.95 M(-23.2%) |
| Dec 2023 | $95.03 M(-63.9%) | $95.03 M(-48.3%) |
| Sept 2023 | - | $183.96 M(-32.2%) |
| June 2023 | - | $271.41 M(+2.2%) |
| Mar 2023 | - | $265.67 M(+0.9%) |
| Dec 2022 | $263.33 M(+267.2%) | $263.33 M(+222.5%) |
| Sept 2022 | - | $81.65 M(-3.3%) |
| June 2022 | - | $84.40 M(+38.3%) |
| Mar 2022 | - | $61.01 M(-14.9%) |
| Dec 2021 | $71.71 M(+86.2%) | $71.71 M(+29.0%) |
| Sept 2021 | - | $55.61 M(+22.4%) |
| June 2021 | - | $45.43 M(+34.7%) |
| Mar 2021 | - | $33.74 M(-12.4%) |
| Dec 2020 | $38.50 M(-21.7%) | $38.50 M(-70.4%) |
| Sept 2020 | - | $130.27 M(-0.5%) |
| June 2020 | - | $130.86 M(-0.8%) |
| Mar 2020 | - | $131.97 M(+168.5%) |
| Dec 2019 | $49.15 M(+82.8%) | $49.15 M(-3.0%) |
| Sept 2019 | - | $50.69 M(+2.5%) |
| June 2019 | - | $49.45 M(+9.7%) |
| Mar 2019 | - | $45.10 M(+67.7%) |
| Dec 2018 | $26.88 M(-6.1%) | $26.88 M(+24.2%) |
| Sept 2018 | - | $21.65 M(-2.8%) |
| June 2018 | - | $22.26 M(-10.8%) |
| Mar 2018 | - | $24.95 M(-12.9%) |
| Dec 2017 | $28.64 M | $28.64 M(-5.5%) |
| Sept 2017 | - | $30.29 M(-15.1%) |
| June 2017 | - | $35.69 M(+0.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2017 | - | $35.44 M(+4.9%) |
| Dec 2016 | $33.77 M(-11.5%) | $33.77 M(+5.2%) |
| Sept 2016 | - | $32.11 M(-5.0%) |
| June 2016 | - | $33.81 M(+5.6%) |
| Mar 2016 | - | $32.01 M(-16.2%) |
| Dec 2015 | $38.18 M(+21.2%) | $38.18 M(-1.5%) |
| Sept 2015 | - | $38.75 M(-0.7%) |
| June 2015 | - | $39.02 M(+1.6%) |
| Mar 2015 | - | $38.41 M(+22.0%) |
| Dec 2014 | $31.49 M(+39.6%) | $31.49 M(+8.1%) |
| Sept 2014 | - | $29.14 M(+4.2%) |
| June 2014 | - | $27.97 M(+24.2%) |
| Mar 2014 | - | $22.51 M(-0.2%) |
| Dec 2013 | $22.55 M(+53.0%) | $22.55 M(+0.3%) |
| Sept 2013 | - | $22.48 M(+48.9%) |
| June 2013 | - | $15.09 M(+11.1%) |
| Mar 2013 | - | $13.58 M(-7.9%) |
| Dec 2012 | $14.74 M(-23.9%) | $14.74 M(+8.2%) |
| Sept 2012 | - | $13.63 M(-8.7%) |
| June 2012 | - | $14.93 M(-24.6%) |
| Mar 2012 | - | $19.80 M(+2.2%) |
| Dec 2011 | $19.38 M(-7.0%) | $19.38 M(-8.3%) |
| Sept 2011 | - | $21.13 M(-1.5%) |
| June 2011 | - | $21.46 M(-11.1%) |
| Mar 2011 | - | $24.13 M(+15.8%) |
| Dec 2010 | $20.84 M(+147.5%) | $20.84 M(-9.0%) |
| Sept 2010 | - | $22.91 M(+42.2%) |
| June 2010 | - | $16.11 M(+91.4%) |
| Dec 2009 | $8.42 M(+79.1%) | $8.42 M |
| Dec 2008 | $4.70 M | - |
FAQ
- What is Pacific Biosciences of California annual total current liabilities?
- What is the all time high annual current liabilities for Pacific Biosciences of California?
- What is Pacific Biosciences of California annual current liabilities year-on-year change?
- What is Pacific Biosciences of California quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Pacific Biosciences of California?
- What is Pacific Biosciences of California quarterly current liabilities year-on-year change?
What is Pacific Biosciences of California annual total current liabilities?
The current annual current liabilities of PACB is $95.03 M
What is the all time high annual current liabilities for Pacific Biosciences of California?
Pacific Biosciences of California all-time high annual total current liabilities is $263.33 M
What is Pacific Biosciences of California annual current liabilities year-on-year change?
Over the past year, PACB annual total current liabilities has changed by -$168.31 M (-63.91%)
What is Pacific Biosciences of California quarterly total current liabilities?
The current quarterly current liabilities of PACB is $60.00 M
What is the all time high quarterly current liabilities for Pacific Biosciences of California?
Pacific Biosciences of California all-time high quarterly total current liabilities is $271.41 M
What is Pacific Biosciences of California quarterly current liabilities year-on-year change?
Over the past year, PACB quarterly total current liabilities has changed by -$123.96 M (-67.39%)